InstalabLoading...
InstalabLoading...
A measure of blood sugar concentration that reveals how well your body regulates its primary fuel, serving as the cornerstone test for diagnosing prediabetes and diabetes.
Your fasting glucose level is the most fundamental metabolic number you can know. Glucose is the sugar your cells use as their primary fuel, and your body works hard to keep its concentration in a narrow band. When this regulation falters, the consequences ripple across nearly every organ system. A single fasting blood draw can tell you whether your blood sugar control is healthy, starting to slip, or already in a disease range.
In a normal fasting state, glucose is tightly maintained between 70 and 100 mg/dL (3.9 to 5.5 mmol/L). Staying in this range depends on a finely tuned conversation between your pancreas, liver, muscles, and fat tissue. When blood sugar rises after a meal, your pancreas releases insulin, which signals cells to absorb glucose. When blood sugar drops, your liver releases stored glucose to keep levels from falling too low. The precision of this system is remarkable, and fasting glucose is your simplest readout of how well it is working.
Glucose testing provides the clearest diagnostic boundaries in metabolic medicine. The thresholds below apply equally to adults and children and are used worldwide to classify blood sugar status.
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| Fasting plasma glucose | Below 100 mg/dL | 100 to 125 mg/dL | 126 mg/dL or higher |
| 2-hour glucose after oral glucose tolerance test (75 g) | Below 140 mg/dL | 140 to 199 mg/dL | 200 mg/dL or higher |
| Random glucose with symptoms | Not applicable | Not applicable | 200 mg/dL or higher |
What this means for you: a fasting glucose between 100 and 125 mg/dL places you in the prediabetes range. This is not yet diabetes, but it tells you that your body's ability to regulate blood sugar is eroding. This is a window of opportunity. The progression from prediabetes to diabetes is not inevitable, and lifestyle changes at this stage are remarkably effective.
If your fasting glucose is normal but you have other risk factors (family history, elevated waist circumference, high triglycerides), an oral glucose tolerance test can unmask problems that fasting glucose alone may miss. Some people maintain normal fasting levels while their post-meal glucose spikes into concerning territory.
The diagnostic cutoffs tell you where disease begins, but "below 100 mg/dL" is not the whole story. Within the normal range, not all values carry the same long-term outlook. A prospective study of over 12.4 million Korean adults followed for up to 12 years found a J-shaped relationship between fasting glucose and death from all causes. The fasting glucose range associated with the lowest mortality was 80 to 94 mg/dL, and this held regardless of sex or age group.
Below that range, particularly below 70 mg/dL, mortality risk rose again, suggesting that chronically low glucose also carries risk and warrants clinical follow-up. Above it, the relationship was continuous: even within the prediabetes range of 100 to 125 mg/dL, each 18 mg/dL (1 mmol/L) increase in fasting glucose was associated with a 13% increase in mortality. The strength of this association was most pronounced in younger adults. Among those aged 18 to 34 years, each 18 mg/dL increase in the prediabetes range was linked to a 30% higher mortality risk, while in adults aged 75 and older the same increase carried a 10% higher risk.
This means that a fasting glucose of 95 mg/dL, while technically "normal," is not metabolically equivalent to a level of 85 mg/dL. If you are proactively managing your health, aiming for the 80 to 94 mg/dL range is a reasonable target. That said, this data comes from a large Korean cohort and the authors note that while the optimal range was consistent across sex and age groups, the magnitude of risk may vary in populations with different body composition, smoking patterns, and healthcare access.
A single fasting glucose measurement is a snapshot. But emerging evidence shows that the swings in your blood sugar over time, not just the average level, carry independent health consequences. Large fluctuations in glucose cause more damage to blood vessel linings and generate more oxidative stress than a steady, moderately elevated level.
Long-term variability in fasting glucose and HbA1c (a measure of average blood sugar over three months) is associated with increased risk of cardiovascular disease, kidney disease, eye damage, nerve damage, and death. For kidney complications specifically, higher glucose variability has been linked to a 34 to 56% increase in risk. For diabetic eye disease, the risk roughly doubles. These associations persist even after accounting for average glucose levels and medication use.
Increased fasting glucose and HbA1c variability are also associated with all-cause mortality, with risk increases of 50 to 300% for dangerous low blood sugar episodes in the setting of higher variability. Even in people with well-controlled average glucose (as measured by HbA1c), within-day variability captured by CGM is associated with 10-year cardiovascular risk. This underscores why both the average and the stability of your glucose matter.
Fasting glucose responds to the same lifestyle interventions that improve insulin resistance, because the two are mechanistically linked. When your cells resist insulin, your liver overproduces glucose and your muscles absorb less of it, pushing fasting levels upward.
Weight loss and dietary change are the foundation. The Diabetes Prevention Program showed that 7% weight loss combined with 150 minutes of weekly moderate exercise reduced new diabetes cases by 58% over 2.8 years. The Finnish Diabetes Prevention Study found that participants achieving all five lifestyle goals (at least 5% weight loss, reduced fat intake, increased fiber, and at least 4 hours of weekly exercise) developed zero cases of diabetes over 7 years. The Mediterranean diet improves glucose control even without caloric restriction and outperforms low-fat diets for people who already have diabetes.
Regular physical activity acutely lowers glucose with each session and produces sustained improvements in glucose tolerance over time, even without weight loss. At least 150 minutes per week of moderate-intensity exercise is recommended. Regular endurance exercise preferentially reduces visceral fat, which correlates more closely with metabolic improvement than total weight loss.
When lifestyle measures are not sufficient, several medication classes can lower fasting glucose through distinct mechanisms:
Current guidelines recommend early use of SGLT2 inhibitors or GLP-1 receptor agonists, even before metformin, for people with established cardiovascular or kidney disease, regardless of their starting HbA1c level. This reflects the growing recognition that these medications offer organ protection beyond glucose control. CGM has demonstrated superiority over traditional blood glucose monitoring for people on these therapies, reducing HbA1c by an additional 0.31% on average and decreasing episodes of dangerously low blood sugar.